APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Exoskeleton Systems

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Exoskeleton Systems Market Outlook and Growth Opportunities 2026

Report ID 17440599054 July 2026191 pages

Choose your research edition.

Industry ResearchExoskeleton Systems Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Exoskeleton Systems Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Exoskeleton Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exoskeleton Systems Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Exoskeleton Systems Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Exoskeleton Systems market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Exoskeleton Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Exoskeleton Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exoskeleton Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Exoskeleton Systems market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Exoskeleton Systems market include Cyberdyne, Ekso Bionics, ReWalk Robotics, Rex Bionics, Berkley Robotics, Focal Meditech, Hocoma, Honda and Interactive Motion Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Exoskeleton Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Exoskeleton Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Exoskeleton Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Exoskeleton Systems market size, projected growth trends, production technologies, key applications, and end-use industries.

Exoskeleton Systems Segment by Company

Cyberdyne

Ekso Bionics

ReWalk Robotics

Rex Bionics

Berkley Robotics

Focal Meditech

Hocoma

Honda

Interactive Motion Technologies

LockHeed Martin

Myomo

Parker Hannafin

Raytheon Sarcos

Exoskeleton Systems Segment by Type

Lower Body Exoskeletons

Full Body Exoskeletons

Upper Body Exoskeletons

Exoskeleton Systems Segment by Application

Military

Industrial

Construction

Healthcare

Other

Exoskeleton Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Exoskeleton Systems status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Exoskeleton Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Exoskeleton Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Exoskeleton Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoskeleton Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exoskeleton Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoskeleton Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Exoskeleton Systems market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exoskeleton Systems industry.

Chapter 3: Detailed analysis of Exoskeleton Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Exoskeleton Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Exoskeleton Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Exoskeleton Systems Industry Trends Table 2. Exoskeleton Systems Industry Drivers Table 3. Exoskeleton Systems Industry Opportunities and Challenges Table 4. Exoskeleton Systems Industry Restraints Table 5. Global Exoskeleton Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Exoskeleton Systems Revenue Share by Company (2021-2026) Table 7. Global Exoskeleton Systems Sales Volume by Company (k units) & (2021-2026) Table 8. Global Exoskeleton Systems Sales Volume Share by Company (2021-2026) Table 9. Global Exoskeleton Systems Average Price (USD/unit) of Company (2021-2026) Table 10. Global Exoskeleton Systems Company Ranking, (2024-2026) & (USD Million) Table 11. Global Exoskeleton Systems Key Company Manufacturing Base & Headquarters Table 12. Global Exoskeleton Systems Company, Product Type & Application Table 13. Global Exoskeleton Systems Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Exoskeleton Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lower Body Exoskeletons Table 18. Significant Companies of Full Body Exoskeletons Table 19. Significant Companies of Upper Body Exoskeletons Table 20. Global Exoskeleton Systems Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Exoskeleton Systems Sales Volume by Type (2021-2026) & (k units) Table 22. Global Exoskeleton Systems Sales Volume by Type (2027-2032) & (k units) Table 23. Global Exoskeleton Systems Sales Volume Share by Type (2021-2026) Table 24. Global Exoskeleton Systems Sales Volume Share by Type (2027-2032) Table 25. Global Exoskeleton Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Exoskeleton Systems Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Exoskeleton Systems Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Exoskeleton Systems Sales Value Share by Type (2021-2026) Table 29. Global Exoskeleton Systems Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Military Table 31. Significant Companies of Industrial Table 32. Significant Companies of Construction Table 33. Significant Companies of Healthcare Table 34. Significant Companies of Other Table 35. Global Exoskeleton Systems Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Exoskeleton Systems Sales Volume by Application (2021-2026) & (k units) Table 37. Global Exoskeleton Systems Sales Volume by Application (2027-2032) & (k units) Table 38. Global Exoskeleton Systems Sales Volume Share by Application (2021-2026) Table 39. Global Exoskeleton Systems Sales Volume Share by Application (2027-2032) Table 40. Global Exoskeleton Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Exoskeleton Systems Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Exoskeleton Systems Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Exoskeleton Systems Sales Value Share by Application (2021-2026) Table 44. Global Exoskeleton Systems Sales Value Share by Application (2027-2032) Table 45. Global Exoskeleton Systems Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Exoskeleton Systems Sales by Region (2021-2026) & (k units) Table 47. Global Exoskeleton Systems Sales Market Share by Region (2021-2026) Table 48. Global Exoskeleton Systems Sales by Region (2027-2032) & (k units) Table 49. Global Exoskeleton Systems Sales Market Share by Region (2027-2032) Table 50. Global Exoskeleton Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Exoskeleton Systems Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Exoskeleton Systems Sales Value Share by Region (2021-2026) Table 53. Global Exoskeleton Systems Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Exoskeleton Systems Sales Value Share by Region (2027-2032) Table 55. Global Exoskeleton Systems Market Average Price (USD/unit) by Region (2021-2026) Table 56. Global Exoskeleton Systems Market Average Price (USD/unit) by Region (2027-2032) Table 57. Global Exoskeleton Systems Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Exoskeleton Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Exoskeleton Systems Sales by Country (2021-2026) & (k units) Table 60. Global Exoskeleton Systems Sales Market Share by Country (2021-2026) Table 61. Global Exoskeleton Systems Sales by Country (2027-2032) & (k units) Table 62. Global Exoskeleton Systems Sales Market Share by Country (2027-2032) Table 63. Global Exoskeleton Systems Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Exoskeleton Systems Sales Value Market Share by Country (2021-2026) Table 65. Global Exoskeleton Systems Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Exoskeleton Systems Sales Value Market Share by Country (2027-2032) Table 67. Cyberdyne Company Information Table 68. Cyberdyne Business Overview Table 69. Cyberdyne Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Cyberdyne Exoskeleton Systems Product Portfolio Table 71. Cyberdyne Recent Development Table 72. Ekso Bionics Company Information Table 73. Ekso Bionics Business Overview Table 74. Ekso Bionics Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Ekso Bionics Exoskeleton Systems Product Portfolio Table 76. Ekso Bionics Recent Development Table 77. ReWalk Robotics Company Information Table 78. ReWalk Robotics Business Overview Table 79. ReWalk Robotics Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. ReWalk Robotics Exoskeleton Systems Product Portfolio Table 81. ReWalk Robotics Recent Development Table 82. Rex Bionics Company Information Table 83. Rex Bionics Business Overview Table 84. Rex Bionics Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Rex Bionics Exoskeleton Systems Product Portfolio Table 86. Rex Bionics Recent Development Table 87. Berkley Robotics Company Information Table 88. Berkley Robotics Business Overview Table 89. Berkley Robotics Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Berkley Robotics Exoskeleton Systems Product Portfolio Table 91. Berkley Robotics Recent Development Table 92. Focal Meditech Company Information Table 93. Focal Meditech Business Overview Table 94. Focal Meditech Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Focal Meditech Exoskeleton Systems Product Portfolio Table 96. Focal Meditech Recent Development Table 97. Hocoma Company Information Table 98. Hocoma Business Overview Table 99. Hocoma Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Hocoma Exoskeleton Systems Product Portfolio Table 101. Hocoma Recent Development Table 102. Honda Company Information Table 103. Honda Business Overview Table 104. Honda Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Honda Exoskeleton Systems Product Portfolio Table 106. Honda Recent Development Table 107. Interactive Motion Technologies Company Information Table 108. Interactive Motion Technologies Business Overview Table 109. Interactive Motion Technologies Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Interactive Motion Technologies Exoskeleton Systems Product Portfolio Table 111. Interactive Motion Technologies Recent Development Table 112. LockHeed Martin Company Information Table 113. LockHeed Martin Business Overview Table 114. LockHeed Martin Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. LockHeed Martin Exoskeleton Systems Product Portfolio Table 116. LockHeed Martin Recent Development Table 117. Myomo Company Information Table 118. Myomo Business Overview Table 119. Myomo Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Myomo Exoskeleton Systems Product Portfolio Table 121. Myomo Recent Development Table 122. Parker Hannafin Company Information Table 123. Parker Hannafin Business Overview Table 124. Parker Hannafin Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Parker Hannafin Exoskeleton Systems Product Portfolio Table 126. Parker Hannafin Recent Development Table 127. Raytheon Sarcos Company Information Table 128. Raytheon Sarcos Business Overview Table 129. Raytheon Sarcos Exoskeleton Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Raytheon Sarcos Exoskeleton Systems Product Portfolio Table 131. Raytheon Sarcos Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Exoskeleton Systems Distributors List Table 135. Exoskeleton Systems Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Exoskeleton Systems Product Image Figure 2. Global Exoskeleton Systems Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exoskeleton Systems Sales Value (2021-2032) & (US$ Million) Figure 4. Global Exoskeleton Systems Sales (2021-2032) & (k units) Figure 5. Global Exoskeleton Systems Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Exoskeleton Systems Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lower Body Exoskeletons Image Figure 10. Full Body Exoskeletons Image Figure 11. Upper Body Exoskeletons Image Figure 12. Global Exoskeleton Systems Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Exoskeleton Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Exoskeleton Systems Sales Volume Share by Type (2021-2032) Figure 15. Global Exoskeleton Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Exoskeleton Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Exoskeleton Systems Sales Value Share by Type (2021-2032) Figure 18. Military Image Figure 19. Industrial Image Figure 20. Construction Image Figure 21. Healthcare Image Figure 22. Other Image Figure 23. Global Exoskeleton Systems Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Exoskeleton Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Exoskeleton Systems Sales Volume Share by Application (2021-2032) Figure 26. Global Exoskeleton Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Exoskeleton Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Exoskeleton Systems Sales Value Share by Application (2021-2032) Figure 29. Global Exoskeleton Systems Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Exoskeleton Systems Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Exoskeleton Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Exoskeleton Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Exoskeleton Systems Sales Value (2021-2032) & (US$ Million) Figure 34. North America Exoskeleton Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Exoskeleton Systems Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Exoskeleton Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Exoskeleton Systems Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Exoskeleton Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Exoskeleton Systems Sales Value (2021-2032) & (US$ Million) Figure 40. South America Exoskeleton Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Exoskeleton Systems Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Exoskeleton Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Exoskeleton Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Exoskeleton Systems Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Exoskeleton Systems Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Lower Body Exoskeletons
  • Full Body Exoskeletons
  • Upper Body Exoskeletons
Applications
  • Military
  • Industrial
  • Construction
  • Healthcare
  • Other
Companies covered
  • Cyberdyne
  • Ekso Bionics
  • ReWalk Robotics
  • Rex Bionics
  • Berkley Robotics
  • Focal Meditech
  • Hocoma
  • Honda
  • Interactive Motion Technologies
  • LockHeed Martin
  • Myomo
  • Parker Hannafin
  • Raytheon Sarcos

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Exoskeleton Systems Sales Value (2021-2032)
  4. 1.2.2 Global Exoskeleton Systems Sales Volume (2021-2032)
  5. 1.2.3 Global Exoskeleton Systems Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Exoskeleton Systems Market Dynamics
  1. 2.1 Exoskeleton Systems Industry Trends
  2. 2.2 Exoskeleton Systems Industry Drivers
  3. 2.3 Exoskeleton Systems Industry Opportunities and Challenges
  4. 2.4 Exoskeleton Systems Industry Restraints
3 Exoskeleton Systems Market by Company
  1. 3.1 Global Exoskeleton Systems Company Revenue Ranking in 2025
  2. 3.2 Global Exoskeleton Systems Revenue by Company (2021-2026)
  3. 3.3 Global Exoskeleton Systems Sales Volume by Company (2021-2026)
  4. 3.4 Global Exoskeleton Systems Average Price by Company (2021-2026)
  5. 3.5 Global Exoskeleton Systems Company Ranking (2024-2026)
  6. 3.6 Global Exoskeleton Systems Company Manufacturing Base and Headquarters
  7. 3.7 Global Exoskeleton Systems Company Product Type and Application
  8. 3.8 Global Exoskeleton Systems Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Exoskeleton Systems Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Exoskeleton Systems Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Exoskeleton Systems Market by Type
  1. 4.1 Exoskeleton Systems Type Introduction
  2. 4.1.1 Lower Body Exoskeletons
  3. 4.1.2 Full Body Exoskeletons
  4. 4.1.3 Upper Body Exoskeletons
  5. 4.2 Global Exoskeleton Systems Sales Volume by Type
  6. 4.2.1 Global Exoskeleton Systems Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Exoskeleton Systems Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Exoskeleton Systems Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Exoskeleton Systems Sales Value by Type
  10. 4.3.1 Global Exoskeleton Systems Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Exoskeleton Systems Sales Value by Type (2021-2032)
  12. 4.3.3 Global Exoskeleton Systems Sales Value Share by Type (2021-2032)
5 Exoskeleton Systems Market by Application
  1. 5.1 Exoskeleton Systems Application Introduction
  2. 5.1.1 Military
  3. 5.1.2 Industrial
  4. 5.1.3 Construction
  5. 5.1.4 Healthcare
  6. 5.1.5 Other
  7. 5.2 Global Exoskeleton Systems Sales Volume by Application
  8. 5.2.1 Global Exoskeleton Systems Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Exoskeleton Systems Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Exoskeleton Systems Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Exoskeleton Systems Sales Value by Application
  12. 5.3.1 Global Exoskeleton Systems Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Exoskeleton Systems Sales Value by Application (2021-2032)
  14. 5.3.3 Global Exoskeleton Systems Sales Value Share by Application (2021-2032)
6 Exoskeleton Systems Regional Sales and Value Analysis
  1. 6.1 Global Exoskeleton Systems Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Exoskeleton Systems Sales by Region (2021-2032)
  3. 6.2.1 Global Exoskeleton Systems Sales by Region: 2021-2026
  4. 6.2.2 Global Exoskeleton Systems Sales by Region (2027-2032)
  5. 6.3 Global Exoskeleton Systems Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Exoskeleton Systems Sales Value by Region (2021-2032)
  7. 6.4.1 Global Exoskeleton Systems Sales Value by Region: 2021-2026
  8. 6.4.2 Global Exoskeleton Systems Sales Value by Region (2027-2032)
  9. 6.5 Global Exoskeleton Systems Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Exoskeleton Systems Sales Value (2021-2032)
  12. 6.6.2 North America Exoskeleton Systems Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Exoskeleton Systems Sales Value (2021-2032)
  15. 6.7.2 Europe Exoskeleton Systems Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Exoskeleton Systems Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Exoskeleton Systems Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Exoskeleton Systems Sales Value (2021-2032)
  21. 6.9.2 South America Exoskeleton Systems Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Exoskeleton Systems Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Exoskeleton Systems Sales Value Share by Country, 2025 VS 2032
7 Exoskeleton Systems Country-level Sales and Value Analysis
  1. 7.1 Global Exoskeleton Systems Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Exoskeleton Systems Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Exoskeleton Systems Sales by Country (2021-2032)
  4. 7.3.1 Global Exoskeleton Systems Sales by Country (2021-2026)
  5. 7.3.2 Global Exoskeleton Systems Sales by Country (2027-2032)
  6. 7.4 Global Exoskeleton Systems Sales Value by Country (2021-2032)
  7. 7.4.1 Global Exoskeleton Systems Sales Value by Country (2021-2026)
  8. 7.4.2 Global Exoskeleton Systems Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Exoskeleton Systems Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Exoskeleton Systems Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Exoskeleton Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cyberdyne
  2. 8.1.1 Cyberdyne Company Information
  3. 8.1.2 Cyberdyne Business Overview
  4. 8.1.3 Cyberdyne Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cyberdyne Exoskeleton Systems Product Portfolio
  6. 8.1.5 Cyberdyne Recent Developments
  7. 8.2 Ekso Bionics
  8. 8.2.1 Ekso Bionics Company Information
  9. 8.2.2 Ekso Bionics Business Overview
  10. 8.2.3 Ekso Bionics Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ekso Bionics Exoskeleton Systems Product Portfolio
  12. 8.2.5 Ekso Bionics Recent Developments
  13. 8.3 ReWalk Robotics
  14. 8.3.1 ReWalk Robotics Company Information
  15. 8.3.2 ReWalk Robotics Business Overview
  16. 8.3.3 ReWalk Robotics Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 ReWalk Robotics Exoskeleton Systems Product Portfolio
  18. 8.3.5 ReWalk Robotics Recent Developments
  19. 8.4 Rex Bionics
  20. 8.4.1 Rex Bionics Company Information
  21. 8.4.2 Rex Bionics Business Overview
  22. 8.4.3 Rex Bionics Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Rex Bionics Exoskeleton Systems Product Portfolio
  24. 8.4.5 Rex Bionics Recent Developments
  25. 8.5 Berkley Robotics
  26. 8.5.1 Berkley Robotics Company Information
  27. 8.5.2 Berkley Robotics Business Overview
  28. 8.5.3 Berkley Robotics Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Berkley Robotics Exoskeleton Systems Product Portfolio
  30. 8.5.5 Berkley Robotics Recent Developments
  31. 8.6 Focal Meditech
  32. 8.6.1 Focal Meditech Company Information
  33. 8.6.2 Focal Meditech Business Overview
  34. 8.6.3 Focal Meditech Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Focal Meditech Exoskeleton Systems Product Portfolio
  36. 8.6.5 Focal Meditech Recent Developments
  37. 8.7 Hocoma
  38. 8.7.1 Hocoma Company Information
  39. 8.7.2 Hocoma Business Overview
  40. 8.7.3 Hocoma Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hocoma Exoskeleton Systems Product Portfolio
  42. 8.7.5 Hocoma Recent Developments
  43. 8.8 Honda
  44. 8.8.1 Honda Company Information
  45. 8.8.2 Honda Business Overview
  46. 8.8.3 Honda Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Honda Exoskeleton Systems Product Portfolio
  48. 8.8.5 Honda Recent Developments
  49. 8.9 Interactive Motion Technologies
  50. 8.9.1 Interactive Motion Technologies Company Information
  51. 8.9.2 Interactive Motion Technologies Business Overview
  52. 8.9.3 Interactive Motion Technologies Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Interactive Motion Technologies Exoskeleton Systems Product Portfolio
  54. 8.9.5 Interactive Motion Technologies Recent Developments
  55. 8.10 LockHeed Martin
  56. 8.10.1 LockHeed Martin Company Information
  57. 8.10.2 LockHeed Martin Business Overview
  58. 8.10.3 LockHeed Martin Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 LockHeed Martin Exoskeleton Systems Product Portfolio
  60. 8.10.5 LockHeed Martin Recent Developments
  61. 8.11 Myomo
  62. 8.11.1 Myomo Company Information
  63. 8.11.2 Myomo Business Overview
  64. 8.11.3 Myomo Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Myomo Exoskeleton Systems Product Portfolio
  66. 8.11.5 Myomo Recent Developments
  67. 8.12 Parker Hannafin
  68. 8.12.1 Parker Hannafin Company Information
  69. 8.12.2 Parker Hannafin Business Overview
  70. 8.12.3 Parker Hannafin Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Parker Hannafin Exoskeleton Systems Product Portfolio
  72. 8.12.5 Parker Hannafin Recent Developments
  73. 8.13 Raytheon Sarcos
  74. 8.13.1 Raytheon Sarcos Company Information
  75. 8.13.2 Raytheon Sarcos Business Overview
  76. 8.13.3 Raytheon Sarcos Exoskeleton Systems Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Raytheon Sarcos Exoskeleton Systems Product Portfolio
  78. 8.13.5 Raytheon Sarcos Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Exoskeleton Systems Value Chain Analysis
  2. 9.1.1 Exoskeleton Systems Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Exoskeleton Systems Sales Mode & Process
  6. 9.2 Exoskeleton Systems Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Exoskeleton Systems Distributors
  9. 9.2.3 Exoskeleton Systems Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst